Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biovail Receives Canadian Approval for Ralivia(TM) for the Treatment of Moderately Severe Pain
Biovail Receives Canadian Approval for Ralivia(TM) for the Treatment of Moderately Severe Pain
Biovail Receives Canadian Approval for Ralivia(TM) for the Treatment of Moderately Severe Pain
Submitted by
admin
on August 25, 2008 - 2:06pm
Source:
Trading Markets
Headline:
Biovail Receives Canadian Approval for Ralivia(TM) for the Treatment of Moderately Severe Pain
Do Not Allow Advertisers to Use My Personal information
